ADURO BIOTECH, INC.|4Sep 18, 7:00 PM ET

Haghighat Ross 4

4 · ADURO BIOTECH, INC. · Filed Sep 18, 2019

Form 4

Period: 2019-09-16

Director

Transactions

Exercise/Conversion
Common Stock
2019-09-16$0.45/sh+21,451$9,653→ 71,034 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-09-16−21,451→ 0 total
Exercise: $0.45Exp: 2020-03-18→ Common Stock (21,451 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-09-16−4,566→ 0 total
Exercise: $0.45Exp: 2020-03-18→ Common Stock (4,566 underlying)
Exercise/Conversion
Common Stock
2019-09-16$1.00/sh+18,000$18,000→ 49,583 total
Exercise/Conversion
Common Stock
2019-09-16$0.45/sh+2,459$1,107→ 78,059 total
Exercise/Conversion
Common Stock
2019-09-16$0.45/sh+4,566$2,055→ 75,600 total
Exercise/Conversion
Common Stock
2019-09-16$0.52/sh+9,063$4,713→ 87,122 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-09-16−18,000→ 0 total
Exercise: $1.00Exp: 2024-09-14→ Common Stock (18,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-09-16−2,459→ 0 total
Exercise: $0.45Exp: 2020-03-18→ Common Stock (2,459 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2019-09-16−9,063→ 0 total
Exercise: $0.52Exp: 2021-10-24→ Common Stock (9,063 underlying)

Holdings

Footnotes (3)

[F1]The shares are directly held by Triton Systems, Inc. ("Triton"). The reporting person may be deemed to beneficially own the securities held by Triton. The Reporting Person is president, CEO, a director and a shareholder of Triton. The Reporting Person disclaims beneficial ownership of such securities except to the extent of any pecuniary interest therein.
[F2]The shares are directly held by Triton Holdings, LLC ("Holdings"). Triton is the managing member of Holdings. The Reporting Person is president, CEO, a director and a shareholder of Triton. The Reporting Person disclaims beneficial ownership of such securities except to the extent of any pecuniary interest therein.
[F3]Fully vested.

Documents

1 file